ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow shares fell 1.2% to $130.24 Wednesday afternoon as investors awaited quarterly earnings due after the bell. Wall Street focused on subscription growth and backlog, with analysts expecting revenue of $3.53 billion, up 19% year-over-year. The Fed held rates steady, pressuring tech stocks. ServiceNow recently expanded its AI partnership with OpenAI.
Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings

Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings

Sandisk shares jumped 8.5% to $522.41 Wednesday as storage stocks surged after Seagate forecast stronger revenue on AI-driven data-center demand. Traders are positioning ahead of Sandisk’s fiscal Q2 results due Thursday. Sandisk has soared over 1,000% in six months, pushing its value to $69 billion. A new leveraged ETF tracking Sandisk also launched.
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
F5 (FFIV) stock price jumps about 8% after forecast hike and Q1 earnings beat

F5 (FFIV) stock price jumps about 8% after forecast hike and Q1 earnings beat

F5 shares rose 8.5% to $293.37 after the company reported first-quarter revenue of $822 million, up 7% year over year, with systems sales surging 37%. Adjusted earnings per share reached $4.45, compared to $3.84 a year ago. F5 raised its fiscal 2026 revenue growth forecast to 5%-6% and projected second-quarter revenue between $770 million and $790 million.
Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase shares rose 0.2% to $211.24 Wednesday after UK regulators banned a Coinbase ad campaign over crypto risk messaging tied to cost-of-living concerns. The company is expanding into stock trading and event contracts as regulatory scrutiny intensifies. Coinbase’s next earnings report is due Feb. 12. Bitcoin climbed 1.3% to about $89,294.
Newmont stock rises as gold breaks $5,300 — Fed signal and new targets set the tone

Newmont stock rises as gold breaks $5,300 — Fed signal and new targets set the tone

Newmont shares rose 1.5% to $128.93 Wednesday as gold hit a record $5,311.31 an ounce before easing. The Federal Reserve held rates steady, keeping the dollar firm against the euro and yen. BMO and Scotiabank raised Newmont price targets to $145 and $152, respectively. Newmont will report full-year and Q4 results on Feb. 19.
Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks shares rose 1% to $96.56 after swinging more than 10% following Q1 results showing 4% global same-store sales growth and first U.S. increase in two years. Margins fell for the eighth straight quarter, frustrating investors. CEO Brian Niccol cited new drinks as growth drivers but warned service targets will take time. All eyes turn to Thursday’s investor day for margin guidance.
Chevron stock price: CVX inches up after report flags March jump in Venezuelan crude exports

Chevron stock price: CVX inches up after report flags March jump in Venezuelan crude exports

Chevron shares rose 0.3% to $169.48 after reports it plans to raise Venezuelan crude exports to the U.S. to 300,000 barrels per day in March. Brent crude climbed 1.1% to $68.33 a barrel. U.S. officials are preparing a general license for Venezuela’s energy sector, sources said. Chevron also named Thomas W. Horton to its board and will report Q4 earnings Jan. 30.
Uber stock slides as robotaxi partner Waabi raises $1B and Uber rolls out AV Labs

Uber stock slides as robotaxi partner Waabi raises $1B and Uber rolls out AV Labs

Uber shares fell 1.4% to $80.09 Wednesday as Waabi announced a $750 million funding round and a deal to deploy over 25,000 robotaxis on Uber’s platform. Uber also launched “AV Labs” to collect real-world driving data for autonomous vehicle partners. Investors are watching for Uber’s upcoming quarterly report. Lyft and DoorDash shares also slipped.
AT&T stock jumps on upbeat 2026 outlook and $45B return plan — fiber deals in focus

AT&T stock jumps on upbeat 2026 outlook and $45B return plan — fiber deals in focus

AT&T shares rose 4.9% to $24.14 Wednesday after reporting a 3.6% revenue increase to $33.5 billion for the fourth quarter and $4.2 billion in free cash flow. The company reaffirmed plans to return over $45 billion to shareholders through 2028 and projected at least $18 billion in free cash flow by 2026. Trading volume topped 52 million shares. Investors watched pending fiber and spectrum deals and signs of easing wireless churn.
Carvana stock sinks nearly 20% after Gotham short-seller report; Wall Street eyes earnings next

Carvana stock sinks nearly 20% after Gotham short-seller report; Wall Street eyes earnings next

Carvana shares fell 19.5% to $384.57 Wednesday after Gotham City Research accused the company of overstating 2023-2024 earnings by over $1 billion and hiding related-party deals. The stock had closed at $477.72 Tuesday. Carvana did not immediately comment. Investors await the company’s response ahead of its February 18 earnings report.
Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson shares rose 1.2% to $227.06 after the FDA approved Darzalex Faspro for use with the VRd regimen in newly diagnosed multiple myeloma patients ineligible for stem cell transplant. The approval is based on the CEPHEUS trial, which showed improved outcomes. The move comes as Medicare named 15 drugs for future price negotiations, pressuring the sector.

Stock Market Today

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop